Credit Suisse’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$61.7M Buy
1,286,156
+115,662
+10% +$5.55M 0.06% 320
2023
Q4
$76M Buy
1,170,494
+14,053
+1% +$912K 0.07% 267
2023
Q3
$75.6M Sell
1,156,441
-32,525
-3% -$2.13M 0.08% 257
2023
Q2
$69.1M Buy
1,188,966
+30,169
+3% +$1.75M 0.07% 293
2023
Q1
$71.5M Buy
1,158,797
+357,843
+45% +$22.1M 0.07% 280
2022
Q4
$50.9M Buy
800,954
+250,584
+46% +$15.9M 0.05% 380
2022
Q3
$40M Buy
550,370
+2,645
+0.5% +$192K 0.04% 439
2022
Q2
$37.2M Buy
547,725
+19,218
+4% +$1.31M 0.04% 483
2022
Q1
$47.9M Sell
528,507
-147,039
-22% -$13.3M 0.04% 448
2021
Q4
$61.7M Buy
675,546
+46,928
+7% +$4.28M 0.03% 387
2021
Q3
$51M Sell
628,618
-8,345
-1% -$677K 0.03% 463
2021
Q2
$59.4M Buy
636,963
+329,405
+107% +$30.7M 0.03% 438
2021
Q1
$32.9M Buy
307,558
+254,651
+481% +$27.2M 0.02% 669
2020
Q4
$4.62M Buy
+52,907
New +$4.62M ﹤0.01% 1575